Sarepta Therapeutics Q4 Loss Decreases, beats estimates
WASHINGTON (dpa-AFX) - Sarepta Therapeutics (SRPT) reported Loss for fourth quarter that decreased from the same period last year and beat the Street estimates.The company's earnings totaled -$109.24